{"page_content": "ESG Report 2023\nAgios\u2019 Access to Medicines  & Affordable Pricing Philosophy  \nGuiding Principles  Help Inform Our Decisions\nThese values and beliefs underscore our thinking related to access and pricing\nCreate meaningful  \noutcomes for patients\nWe work tirelessly to \nunderstand rare diseases, so we can develop medicines that help address the outcomes that are most important to people living with these diseases.At Agios, we forge deep connections  \nwith patients, providers, policymakers and payers to better meet the needs of people living with rare diseases. Our commitment begins with discovering, \ndeveloping and delivering  \ntransformative medicines that address \npatients\u2019 needs. We build on this commitment by supporting patients throughout their journeys. We provide and participate in programs that increase awareness, support accurate and timely diagnosis and enable access to safe and effective treatments. We pledge to set prices for our \nmedicines that balance the benefits  \nto patients, caregivers, the healthcare \nsystem and society and allow us to help as many people as possible today while investing in innovation to help even more people tomorrow. \nStay connected   \nwith communities\nWe connect directly with patients, caregivers, advocates, providers, payers and policymakers and are invested in collaborating with them to develop new and better solutions.Emphasize  \ntransparency\nWe connect communities with the information they need by sharing our data, values, processes and progress as openly as possible.Ensure sustainability  \nto help more patients\nWe invest in innovation to help more patient communities, while ensuring we continue to serve the patients of today.\n12", "metadata": {"source": "NASDAQ_AGIO_2022.pdf", "page": 11, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}